FDA - Search News

FDA Approves 1st Non-Opioid Pain Medicine in 20 Years

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

U.S. News & World Report · 3h

FDA Approves First New Non-Opioid Pain Pill in Decades

FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

CNN on MSN · 14h

FDA approves first new type of pain medication in 25 years

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

FDA upgrades recall of Lay's potato chips

Newsweek on MSN · 2d

Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States

A recall which was issued across nine states has now been given the highest risk classification by the federal agency.

USA TODAY on MSN · 1d

FDA upgrades Frito-Lay potato chips recall to highest risk level due to undeclared milk

Federal regulators have upgraded a product recall of Lay's Classic Potato Chips to the highest risk level for a batch that may contain undeclared milk ingredients. Last month, Frito-Lay issued a recall warning that more than 6,

Boise State Public Radio · 19h

FDA upgrades recall of Lay's potato chips to most serious level

The problem ingredient identified was "undeclared milk," which poses a risk to those with severe sensitivities or allergies.

23h

US FDA identifies cybersecurity risks in certain patient monitors

The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...

2don MSN

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Live Science44m

FDA approves 'ketamine' nasal spray for depression — here's everything you need to know

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.

FDA Opens Up A New Path To The U.S. Market For This Under 30 Biotech Startup

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

STAT9h

How to protect HHS, FDA, NIH, and other health agencies from political interference

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA Approves 1st Non-Opioid Pain Medicine in 20 Years

FDA upgrades recall of Lay's potato chips

Related topics